Down-Regulation of C9orf86 in Human Breast Cancer Cells Inhibits Cell Proliferation, Invasion and Tumor Growth and Correlates with Survival of Breast Cancer Patients

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Li, Yang Yang ^a   Fu, Sha ^a   Wang, Xiao Pai ^a   Wang, Hai Yun ^a   Zeng, Mu Sheng ^a   Shao, Jian Yong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 9 OPEN READING FRAME 86 PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE ARREST; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OPEN READING FRAME; OVERALL SURVIVAL; SURVIVAL RATE; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RAS PROTEINS;

EID: 84881491987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071764     Document Type: Article

References (34)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Takai Y, Sasaki T, Matozaki T, (2001) Small GTP-binding proteins. Physiol Rev 81: 153-208.
3. Colicelli J, (2004) Human RAS superfamily proteins and related GTPases. Sci STKE 2004: RE13.
4. Wennerberg K, Rossman KL, Der CJ, (2005) The Ras superfamily at a glance. J Cell Sci 118: 843-846.
5. Mitsuuchi Y, Testa JR, (2002) Cytogenetics and molecular genetics of lung cancer. Am J Med Genet 115: 183-188.
6. Grady WM, Markowitz SD, (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3: 101-128.
7. Jaffee EM, Hruban RH, Canto M, Kern SE, (2002) Focus on pancreas cancer. Cancer Cell 2: 25-28.
8. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, et al. (2004) Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 10: 2742-2750.
9. Hendrix A, Maynard D, Pauwels P, Braems G, Denys H, et al. (2010) Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 102: 866-880.
10. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 10: 1251-1256.
11. Montalbano J, Lui K, Sheikh MS, Huang Y, (2009) Identification and characterization of RBEL1 subfamily of GTPases in the Ras superfamily involved in cell growth regulation. J Biol Chem 284: 18129-18142.
12. Montalbano J, Jin W, Sheikh MS, Huang Y, (2007) RBEL1 is a novel gene that encodes a nucleocytoplasmic Ras superfamily GTP-binding protein and is overexpressed in breast cancer. J Biol Chem 282: 37640-37649.
13. Rincon-Arano H, Rosales R, Mora N, Rodriguez-Castaneda A, Rosales C, (2003) R-Ras promotes tumor growth of cervical epithelial cells. Cancer 97: 575-585.
14. Ma D, Bai X, Zou H, Lai Y, Jiang Y, (2010) Rheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL. J Biol Chem 285: 8621-8627.
15. Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM, (2008) Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol Cancer Res 6: 372-382.
16. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD, (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60: 5832-5838.
17. Simpson KJ, Dugan AS, Mercurio AM, (2004) Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64: 8694-8701.
18. Clark EA, Golub TR, Lander ES, Hynes RO, (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535.
19. Suwa H, Ohshio G, Imamura T, Watanabe G, Arii S, et al. (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77: 147-152.
20. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, et al. (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641.
21. Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ, (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9: 1950-1953.
22. Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, et al. (2003) Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 9: 5282-5286.
23. Tompkins V, Hagen J, Zediak VP, Quelle DE, (2006) Identification of novel ARF binding proteins by two-hybrid screening. Cell Cycle 5: 641-646.
24. Weber HO, Samuel T, Rauch P, Funk JO, (2002) Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Oncogene 21: 3207-3212.
25. Korgaonkar C, Zhao L, Modestou M, Quelle DE, (2002) ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol 22: 196-206.
26. Gallagher S, Kefford RF, Rizos H, (2005) Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis. Cell Cycle 4: 465-472.
27. Lindstrom MS, Klangby U, Wiman KG, (2001) p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene 20: 2171-2177.
28. Vestey SB, Sen C, Calder CJ, Perks CM, Pignatelli M, et al. (2004) p14ARF expression in invasive breast cancers and ductal carcinoma in situ-relationships to p53 and Hdm2. Breast Cancer Res 6: R571-585.
29. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, et al. (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83: 803-819.
30. Day CP, Rau KM, Qiu L, Liu CW, Kuo HP, et al. (2006) Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model. Cancer Gene Ther 13: 706-719.
31. Ding Q, He X, Xia W, Hsu JM, Chen CT, et al. (2007) Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Cancer Res 67: 4564-4571.
32. Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, et al. (2010) ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 3: ra9.
33. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, et al. (2009) A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41: 365-370.
34. Chen J, Hu CF, Hou JH, Shao Q, Yan LX, et al. (2010) Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma. J Transl Med 8: 30.